XORTX Therapeutics Inc.

TSXV:XRTX Voorraadrapport

Marktkapitalisatie: CA$6.4m

XORTX Therapeutics Beheer

Beheer criteriumcontroles 2/4

XORTX Therapeutics' CEO is Allen Davidoff, appointed in Jan 2018, has a tenure of 6.83 years. total yearly compensation is $321.96K, comprised of 79.2% salary and 20.8% bonuses, including company stock and options. directly owns 2.37% of the company’s shares, worth CA$150.82K. The average tenure of the management team and the board of directors is 2.9 years and 4.1 years respectively.

Belangrijke informatie

Allen Davidoff

Algemeen directeur

US$322.0k

Totale compensatie

Percentage CEO-salaris79.2%
Dienstverband CEO6.8yrs
Eigendom CEO2.4%
Management gemiddelde ambtstermijn2.9yrs
Gemiddelde ambtstermijn bestuur4.1yrs

Recente managementupdates

Recent updates

Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation

Aug 23
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation

XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business

Apr 01
XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business

We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow

Dec 16
We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow

Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth

Sep 01
Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth

Analyse CEO-vergoeding

Hoe is Allen Davidoff's beloning veranderd ten opzichte van XORTX Therapeutics's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$1m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$322kUS$255k

-US$2m

Sep 30 2023n/an/a

-US$7m

Jun 30 2023n/an/a

-US$7m

Mar 31 2023n/an/a

-US$7m

Dec 31 2022US$321kUS$273k

-US$8m

Sep 30 2022n/an/a

US$1m

Jun 30 2022n/an/a

-US$3m

Mar 31 2022n/an/a

-US$2m

Jan 01 2022n/an/a

-US$2m

Sep 30 2021n/an/a

-US$9m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$3m

Dec 31 2020US$204kUS$154k

-US$1m

Sep 30 2020n/an/a

-US$767k

Jun 30 2020n/an/a

-US$536k

Mar 31 2020n/an/a

-US$362k

Dec 31 2019US$161kUS$148k

-US$485k

Sep 30 2019n/an/a

-US$444k

Jun 30 2019n/an/a

-US$582k

Mar 31 2019n/an/a

-US$660k

Dec 31 2018US$194kUS$141k

-US$3m

Compensatie versus markt: Allen's total compensation ($USD321.96K) is above average for companies of similar size in the Canadian market ($USD171.96K).

Compensatie versus inkomsten: Allen's compensation has increased whilst the company is unprofitable.

CEO

Allen Davidoff (64 yo)

6.8yrs

Tenure

US$321,959

Compensatie

Dr. Allen Warren Davidoff, Ph.D. is Founder of XORTX Therapeutics Inc. (formerly known as XORTX Pharma Corp.) and has been its Chief Executive Officer and President since January 9, 2018. Dr. Davidoff serv...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Allen Davidoff
Founder6.8yrsUS$321.96k2.37%
CA$ 150.8k
James Fairbairn
Chief Financial Officer1.4yrsUS$57.51k0.22%
CA$ 13.7k
Stephen Haworth
Chief Medical Officer3.3yrsUS$173.37k0%
CA$ 0
Stacy Evans
Chief Business Officer2yrsUS$211.33kgeen gegevens
Nick Rigopoulos
Director of Communicationsno datageen gegevensgeen gegevens
David Sans
Director of Corporate Development4.3yrsgeen gegevensgeen gegevens
David MacDonald
Consultant of Clinical Operations2.5yrsgeen gegevens0%
CA$ 0
Charlotte May
Corporate Secretaryno datageen gegevensgeen gegevens

2.9yrs

Gemiddelde duur

60.5yo

Gemiddelde leeftijd

Ervaren management: XRTX's management team is considered experienced (2.9 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Allen Davidoff
Founder6.8yrsUS$321.96k2.37%
CA$ 150.8k
Paul Van Damme
Independent Director6.8yrsUS$8.20k0.22%
CA$ 14.0k
Anthony Giovinazzo
Independent Chair of the Board2.4yrsUS$101.11k0.30%
CA$ 19.0k
Richard Johnson
Member of Clinical Advisory Boardno datageen gegevensgeen gegevens
William Farley
Independent Director3.5yrsUS$7.87k0%
CA$ 0
Raymond Pratt
Independent Director2.9yrsUS$7.37k0%
CA$ 0
Henk E. D. ter Keurs
Member of Scientific Advisory Boardno datageen gegevensgeen gegevens
Federico Maese
Member of Clinical Advisory Board6.1yrsgeen gegevensgeen gegevens
Patrick Treanor
Independent Directorless than a yeargeen gegevens0%
CA$ 0
Petter Bjornstad
Member of Clinical Advisory Board6.1yrsgeen gegevensgeen gegevens
Anjay Rastogi
Member of the Clinical Advisory Board4.7yrsgeen gegevensgeen gegevens
Charles Edelstein
Member of the Advisory Board3.3yrsgeen gegevensgeen gegevens

4.1yrs

Gemiddelde duur

68.5yo

Gemiddelde leeftijd

Ervaren bestuur: XRTX's board of directors are considered experienced (4.1 years average tenure).